Indaptus Therapeutics Net Debt Growth & History (INDP)
Indaptus Therapeutics's net debt was −$8.5M for fiscal 2025.
View full Indaptus Therapeutics company overviewIndaptus Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$8.5M | −$2.8M | — |
| 2024 | 2024-12-31 | −$5.7M | $7.5M | — |
| 2023 | 2023-12-31 | −$13.2M | −$3.6M | — |
| 2022 | 2022-12-31 | −$9.5M | $29.4M | — |
| 2021 | 2021-12-31 | −$39.0M | −$38.3M | — |
| 2020 | 2020-12-31 | −$703,499 | — | — |
Indaptus Therapeutics quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −$8.5M | −$2.8M | — |
| Q3 2025 | 2025-09-30 | −$5.8M | $1.5M | — |
| Q2 2025 | 2025-06-30 | $379,175 | $7.6M | — |
| Q1 2025 | 2025-03-31 | −$3.8M | $5.8M | — |
| Q4 2024 | 2024-12-31 | −$5.7M | $7.5M | — |
| Q3 2024 | 2024-09-30 | −$7.3M | $8.5M | — |
| Q2 2024 | 2024-06-30 | −$7.2M | $5.3M | — |
| Q1 2024 | 2024-03-31 | −$9.6M | −$3.0M | — |
| Q4 2023 | 2023-12-31 | −$13.2M | −$3.6M | — |
| Q3 2023 | 2023-09-30 | −$15.8M | −$9.2M | — |
| Q2 2023 | 2023-06-30 | −$12.5M | $1.7M | — |
| Q1 2023 | 2023-03-31 | −$6.6M | $26.5M | — |
| Q4 2022 | 2022-12-31 | −$9.5M | $29.4M | — |
| Q3 2022 | 2022-09-30 | −$6.6M | — | — |
| Q2 2022 | 2022-06-30 | −$14.1M | $2.2M | — |
| Q1 2022 | 2022-03-31 | −$33.1M | — | — |
| Q4 2021 | 2021-12-31 | −$39.0M | −$38.3M | — |
| Q2 2021 | 2021-06-30 | −$16.4M | — | — |
| Q4 2020 | 2020-12-31 | −$703,499 | — | — |
Indaptus Therapeutics net debt trends
Over the last five fiscal years, Indaptus Therapeutics's net debt decreased from −$703,499 to −$8.5M, a change of −$7.8M. The latest reported quarter, Q4 2025, shows −$8.5M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indaptus Therapeutics source filings ↗